第八版TNM分期中N1b分类对分化型甲状腺癌的预后意义
研究纳入3089例1996至2005年接受甲状腺手术的I/II期分化型甲状腺癌患者,评估N1b分类对疾病特异性生存(DSS)的预后价值。中位随访10.0年,年龄≥55岁患者中N1b较N0(HR=11.0,p<0.001)和N1a(HR=4.2,p=0.013)DSS显著更差。采用将年龄≥55岁N1b归为IIB期的改良TNM分期后,IIB期较IIA期DSS显著更差(HR=2.9,p=0.030)。
要点
- 年龄≥55岁I/II期DTC中,N1b较N0的DSS风险比为11.0(p<0.001)。
- 年龄≥55岁I/II期DTC中,N1b较N1a的DSS风险比为4.2(p=0.013)。
- 改良TNM分期中IIB期较IIA期DSS风险比为2.9(p=0.030)。
核心结论
- N1b分类对I/II期分化型甲状腺癌患者尤其是老年患者具有显著预后意义,采用N1b分类的改良TNM分期可能更有助于预测DSS。
研究设计与样本
- 研究纳入3089例1996至2005年间接受甲状腺手术的I/II期分化型甲状腺癌患者,平均年龄45.6岁,中位随访10.0年。
- 按N分类和淋巴结转移数目评估DSS,并评估一种改良TNM分期:将年龄≥55岁的N1b病例归为IIB期,其余归为IIA期。
主要发现
- 年龄≥55岁患者中,N1b较N0的DSS显著更差(HR=11.0,p<0.001),N1b较N1a的DSS显著更差(HR=4.2,p=0.013)。
- 大容量淋巴结转移组较小容量淋巴结转移组DSS显著更差(HR=3.9,p=0.019),大容量淋巴结转移组较N0组DSS显著更差(HR=10.1,p<0.001)。
- 采用改良TNM分期重新分类后,IIB期患者较IIA期患者DSS显著更差(HR=2.9,p=0.030)。
关键数值与推荐
- 年龄≥55岁患者中,N1b vs N0的DSS风险比HR=11.0(p<0.001)。
- 年龄≥55岁患者中,N1b vs N1a的DSS风险比HR=4.2(p=0.013)。
- 大容量淋巴结转移组 vs 小容量淋巴结转移组的DSS风险比HR=3.9(p=0.019);大容量淋巴结转移组 vs N0组HR=10.1(p<0.001)。
- 改良TNM分期中,IIB期 vs IIA期的DSS风险比HR=2.9(p=0.030)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Regional lymph node metastases (LNM) have prognostic significance in differentiated thyroid cancer (DTC). However, there was no distinction between N1a and N1b in the final staging classification in the eighth edition of the tumor-node-metastasis (TNM) staging system. This study aimed to evaluate the prognostic implication of N1b classification for predicting disease-specific survival (DSS) in DTC patients with stage I/II disease. METHODS: A total of 3089 patients with stage I/II DTC who underwent thyroid surgery between 1996 and 2005 were included. DSS was evaluated according to N classification and number of LNM. A modification of the TNM was assessed that classified N1b cases in patients aged ≥55 years as stage IIB and the remaining cases as stage IIA. RESULTS: The mean patient age was 45.6 years, and the median follow-up period was 10.0 years. In patients aged ≥55 years, patients with N1b had significantly poorer DSS compared to those with N0 (hazard ratio [HR] = 11.0; p < 0.001) and N1a (HR = 4.2; p = 0.013). The large-volume LNM group had significantly poorer DSS compared to the N0 (HR = 10.1; p < 0.001) and small-volume LNM (HR = 3.9; p = 0.019) groups. When patients were reclassified using the modified TNM staging system, DSS was significantly poorer in stage IIB patients than in stage IIA patients (HR = 2.9; p = 0.030). CONCLUSIONS: N1b classification has a significant prognostic implication in patients with stage I/II DTC, especially in older patients. Modified TNM staging employing N1b classification could be more useful for the prediction of DSS.
引用
- Kim M, Jeon MJ, Oh HS, et al. Prognostic Implication of N1b Classification in the Eighth Edition of the Tumor-Node-Metastasis Staging System of Differentiated Thyroid Cancer. Thyroid. 2018. PMID: 29620964. doi:10.1089/thy.2017.0473
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。